VIPERGEN R & D III K/S: Financial statements 2012
CVR: 30355644
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -10,237,000. Equity in the 2012 report amounted to DKK 8,884,000. The solvency ratio was 75.9%.
- Revenue
- DKK 0
- Profit/Loss
- DKK -10,237,000
- Equity
- DKK 8,884,000
- Total Assets
- DKK 11,711,000
Official annual report
Keep an eye on VIPERGEN R & D III K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.